Sigma Planning Corp lowered its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 65.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 649 shares of the semiconductor company's stock after selling 1,219 shares during the period. Sigma Planning Corp's holdings in Synopsys were worth $329,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Kingsview Wealth Management LLC purchased a new stake in Synopsys in the first quarter worth about $239,000. Dorsey & Whitney Trust CO LLC lifted its holdings in shares of Synopsys by 37.3% during the first quarter. Dorsey & Whitney Trust CO LLC now owns 585 shares of the semiconductor company's stock worth $334,000 after purchasing an additional 159 shares during the period. M&G Plc acquired a new stake in Synopsys in the first quarter valued at approximately $1,123,000. Nicolet Advisory Services LLC acquired a new position in Synopsys during the first quarter worth about $262,000. Finally, Jacobi Capital Management LLC lifted its position in Synopsys by 45.3% during the first quarter. Jacobi Capital Management LLC now owns 577 shares of the semiconductor company's stock worth $330,000 after buying an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Synopsys Stock Performance
Shares of NASDAQ:SNPS traded down $27.56 on Friday, hitting $520.75. The stock had a trading volume of 1,025,738 shares, compared to its average volume of 846,867. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38. The firm's 50 day moving average price is $514.14 and its 200-day moving average price is $545.35. The company has a market capitalization of $79.99 billion, a price-to-earnings ratio of 54.02, a price-to-earnings-growth ratio of 3.18 and a beta of 1.08.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 21st. The semiconductor company reported $3.43 earnings per share for the quarter, beating analysts' consensus estimates of $3.28 by $0.15. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.52 billion. Synopsys had a return on equity of 22.09% and a net margin of 24.06%. During the same period last year, the company earned $2.17 earnings per share. The business's revenue was up 12.7% compared to the same quarter last year. As a group, sell-side analysts predict that Synopsys, Inc. will post 9.45 EPS for the current year.
Insider Activity
In other Synopsys news, CEO Sassine Ghazi sold 10,293 shares of Synopsys stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total value of $5,701,189.77. Following the completion of the sale, the chief executive officer now directly owns 62,568 shares in the company, valued at approximately $34,655,789.52. The trade was a 14.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.66% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the stock. Needham & Company LLC reiterated a "buy" rating and set a $640.00 price target on shares of Synopsys in a research report on Tuesday, October 22nd. Robert W. Baird raised their price target on shares of Synopsys from $661.00 to $663.00 and gave the company an "outperform" rating in a research report on Thursday, August 22nd. Berenberg Bank started coverage on shares of Synopsys in a research note on Tuesday, October 15th. They set a "buy" rating and a $660.00 target price for the company. Rosenblatt Securities restated a "buy" rating and set a $635.00 price objective on shares of Synopsys in a research report on Friday, August 23rd. Finally, Piper Sandler decreased their price objective on Synopsys from $687.00 to $670.00 and set an "overweight" rating for the company in a report on Thursday, October 24th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, Synopsys currently has an average rating of "Buy" and a consensus target price of $649.82.
View Our Latest Report on SNPS
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.